NovaVel

Open Access

Advancing Knowledge Through Open Access

NovaVel supports the broad dissemination of scholarly research by providing open access to published research. Open Access enables readers worldwide to access scholarly articles online without subscription barriers.

Open Access at NovaVel

NovaVel is committed to making scholarly research accessible to researchers, practitioners, educators, students and readers worldwide.

Articles published in Natural Products and Translational Medicine (NPTM) are made freely accessible online in accordance with the journal's Open Access and licensing policies.

Open Access supports wider dissemination of research and facilitates the responsible sharing of scholarly knowledge.

Free to Read

Published Open Access articles are freely accessible online to readers.

Global Accessibility

Researchers and readers can access published research without subscription barriers.

Transparent Licensing

The conditions governing reuse and distribution are clearly defined through the journal's applicable Creative Commons licence.

Copyright and Licensing

Authors retain copyright in articles published in Natural Products and Translational Medicine (NPTM).

NPTM articles are published under the:

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (CC BY-NC-ND 4.0).

Under this licence, published material may be shared for non-commercial purposes provided appropriate credit is given to the authors and original publication, a link to the licence is provided, and the material is not distributed in modified form.

Open Access

CC BY-NC-ND 4.0

Introductory APC Waiver for NPTM

To support the launch of Natural Products and Translational Medicine (NPTM) and encourage participation from the international research community, NovaVel is providing a 100% waiver of Article Processing Charges (APCs) for the first 24 months from the journal's official launch date.

APC Waiver — Natural Products and Translational Medicine
Official Launch Date30 September 2026
100% APC Waiver Period30 September 2026 – 29 September 2028
APC During Waiver PeriodNo Article Processing Charge
Manuscript Submission FeeNo submission fee

Following completion of the introductory waiver period, an Article Processing Charge may apply to accepted articles. Details of the applicable APC and any waiver or discount provisions will be announced transparently before implementation.

APCs and APC waivers do not influence editorial evaluation, peer review or editorial decisions.

View APC Information

Sharing and Self-Archiving

NovaVel supports responsible scholarly sharing and self-archiving in accordance with the applicable journal repository and licensing policies.

Authors should consult the journal's Repository and Self-Archiving Policy for information concerning the sharing of manuscript versions and published articles.

View Repository & Self-Archiving Policy
1

Author's Original Manuscript

Pre-submission version

2

Accepted Manuscript

Post peer review, pre-typesetting

3

Version of Record

Final published article

Our Journal

Open Access at NPTM

Natural Products and Translational Medicine is an international peer-reviewed journal operating at the interface of natural products, drug discovery, experimental therapeutics and translational medicine.

NPTM provides a platform for research that advances natural-source discoveries toward biological validation and potential therapeutic translation.

Transparent Publishing Policies

NovaVel provides clearly accessible publishing policies to help authors, editors, reviewers and readers understand the principles and procedures governing scholarly publication.

View All Publishing Policies

Publish and Discover Research with NovaVel

Explore Natural Products and Translational Medicine and learn more about its scope, editorial policies and publishing process.